Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
tarextumab (OMP-59R5)
i
Other names:
OMP-59R5, anti-Notch 2/3 monoclonal antibody, TRXT
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Mereo Biopharma, Novartis
Drug class:
Notch-2 receptor inhibitor, Notch-3 receptor inhibitor
Related drugs:
‹
AL101 (1)
AL101 (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
NOTCH3 overexpression
Pancreatic Cancer
NOTCH3 overexpression
Pancreatic Cancer
OMP-59R5
Sensitive: C2 – Inclusion Criteria
OMP-59R5
Sensitive
:
C2
OMP-59R5
Sensitive: C2 – Inclusion Criteria
OMP-59R5
Sensitive
:
C2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.